## Abstract Flowerlike porous carbonated hydroxyapatite (CHAp) spheres were synthesized by the template‐directed homogeneous precipitation method. The carbonate content of synthetic CHAp determined by carbon elemental analysis was about 1.50 wt/wt. FT‐IR and XRD were employed to analyze the chemica
Development, characterization, and validation of porous carbonated hydroxyapatite bone cement
✍ Scribed by Pei-Fu Tang; Gang Li; Ji-Fang Wang; Qiu-Jian Zheng; Yan Wang
- Publisher
- John Wiley and Sons
- Year
- 2009
- Tongue
- English
- Weight
- 461 KB
- Volume
- 90B
- Category
- Article
- ISSN
- 1552-4973
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
Carbonated hydroxyapatite (CHA) bone cement is capable of self‐setting and forming structures similar to mineralized bone. Conventional CHA leaves little room for new bone formation and delays remodeling. The purposes of this study were to develop porous CHA (PCHA) bone cement and to investigate its physicochemical properties, biocompatibility, biodegradation, and in vivo bone repair potential. Vesicants were added to modify CHA, and the solidification time, porosity, and pore size of the PCHA cements were examined. The cytotoxicity and bone repair potential of PCHA were tested in a rabbit bone defect model and assessed by x‐ray, histological examination, and mechanical testing. The porosity of the modified PCHA was 36%; 90.23% of the pores were greater than 70 μm, with a calcium/phosphate ratio of 1.64 and a solidification time of 15 minutes. The PCHA did not affect bone cell growth in vitro, and the degrading time of the PCHA was two and four times faster in vitro and in vivo when compared to CHA. In the bone defect model, the amount of new bone formation in the PCHA‐treated group was eight times greater than that of the CHA group; the compressive strength of the PCHA setting was relatively weak in the first weeks but increased significantly at 8 to 16 weeks compared to the CHA group. The PCHA has stable physicochemical properties and excellent biocompatibility; it degrades faster than CHA, provides more porous spaces for new bone ingrowths, and may be a new form of bone cement for the management of bone defects. © 2009 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 2009
📜 SIMILAR VOLUMES
Ultrasonic parameters such as velocity of sound and broad-band ultrasonic attenuation (BUA) are sensitive to changes in the viscoelastic properties of a material. Bone cement undergoes changes is these properties as it cures. By monitoring the propagation of ultrasonic pulses through a sample of cur
## Abstract In the present study, a calcium carbonate and calcium oxide loaded nano‐hydroxyapatite/chitosan bone cement was developed and its __in vitro__ cell responses were investigated. The physico‐chemical properties were represented in terms of setting time, compressive strength, and wettabili
## Abstract Tissue‐engineering scaffold‐based strategies have suffered from limited cell depth viability when cultured __in vitro__, with viable cells existing within the outer periphery of the fluid–scaffold interface. This is primarily believed to be due to the lack of nutrient delivery into and
## Abstract A novel filter material for separating and eliminating microorganisms in water and gas was fabricated by incorporating silver ions into porous hydroxyapatite (HA) ceramics prepared by a starch additive technique. The porous ceramics reveal a microstructure of both large and small pores.
## Abstract Poly (methyl methacrylate) (PMMA) bone cement is widely used in vertebral body augmentation procedures such as vertebroplasty and balloon kyphoplasty. Filling high modulus PMMA increases the modulus of filled verterbra, increasing the risk of fracture in the adjacent vertebra. On the ot